Literature DB >> 4044629

Dysplasia in Barrett's esophagus.

H G Schmidt, R H Riddell, B Walther, D B Skinner, J F Riemann.   

Abstract

In a retrospective histological study, resected specimens obtained from 23 patients with adenocarcinoma in Barrett's esophagus (Group I) and endoscopic multiple (step) biopsies from 38 patients without carcinoma in Barrett's esophagus (Group II) were investigated for dysplastic changes. Dysplasia was most frequently found in the type of mucosa comprising intestinal metaplasia. There seem to be two pathways to dysplasia in Barrett's esophagus. In Group I dysplasia was found in 18 out of 23, and in Group II in 2 out of 38 patients. In Barrett's esophagus, dysplasia may be considered not only a precursor of carcinoma, but also a marker for coexisting carcinoma.

Entities:  

Mesh:

Year:  1985        PMID: 4044629     DOI: 10.1007/BF00402729

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  25 in total

1.  Malignant transformation of esophageal columnar epithelium.

Authors:  M M Berenson; R H Riddell; D B Skinner; J W Freston
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

2.  Multiple adenomatous neoplasms arising in columnarlined (Barrett's) esophagus.

Authors:  G B McDonald; D L Brand; D R Thorning
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

3.  Cell proliferation in esophageal columnar epithelium (Barrett's esophagus).

Authors:  J J Herbst; M M Berenson; D W McCloskey; W C Wiser
Journal:  Gastroenterology       Date:  1978-10       Impact factor: 22.682

4.  Tissue demonstration of carcinoembryonic antigen (CEA) in columnar esophageal epithelium.

Authors:  K Geboes; M J Vanstapel; V J Desmet; G Vantrappen
Journal:  Hepatogastroenterology       Date:  1981-12

5.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

6.  Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia.

Authors:  R J Kalish; P E Clancy; M B Orringer; H D Appelman
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

7.  Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus.

Authors:  R C Haggitt; J Tryzelaar; F H Ellis; H Colcher
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

8.  Mucin histochemistry of the columnar epithelium of the oesophagus: a retrospective study.

Authors:  J R Jass
Journal:  J Clin Pathol       Date:  1981-08       Impact factor: 3.411

9.  Dysplasia of the gastric mucosa and its relation to the precancerous state.

Authors:  T Nagayo
Journal:  Gan       Date:  1981-12

10.  Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction.

Authors:  J J Thompson; K R Zinsser; H T Enterline
Journal:  Hum Pathol       Date:  1983-01       Impact factor: 3.466

View more
  27 in total

1.  Time gated fluorescence spectroscopy in Barrett's oesophagus.

Authors:  M-A E J Ortner; B Ebert; E Hein; K Zumbusch; D Nolte; U Sukowski; J Weber-Eibel; B Fleige; M Dietel; M Stolte; G Oberhuber; R Porschen; B Klump; H Hörtnagl; H Lochs; H Rinneberg
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 2.  Barrett's esophagus.

Authors:  Jeffrey H Peters; Jeffrey A Hagen; Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

3.  Gastroesophageal reflux disease: relationship between clinical and histological features. GOSPE. Gruppo Operativo per lo Studio delle Precancerosi dell'Esofago.

Authors:  H Aste; L Bonelli; R Ferraris; M Conio; G Lapertosa
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

4.  The effect of reactive atypia/inflammation on the laser-induced fluorescence diagnosis of non-dysplastic Barrett's esophagus.

Authors:  Masoud Panjehpour; Bergein F Overholt; Tuan Vo-Dinh; Domenico Coppola
Journal:  Lasers Surg Med       Date:  2012-04-25       Impact factor: 4.025

5.  Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus.

Authors:  Ewa E Hennig; Michal Mikula; Janina Orlowska; Dorota Jarosz; Andrzej Bielasik; Jaroslaw Regula; Jerzy Ostrowski
Journal:  J Mol Med (Berl)       Date:  2007-10-19       Impact factor: 4.599

6.  Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics.

Authors:  Jerzy Ostrowski; Michal Mikula; Jakub Karczmarski; Tymon Rubel; Lucjan S Wyrwicz; Piotr Bragoszewski; Pawel Gaj; Michal Dadlez; Eugeniusz Butruk; Jaroslaw Regula
Journal:  J Mol Med (Berl)       Date:  2007-03-30       Impact factor: 4.599

7.  Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett's esophagus: the need for long-term subjective and objective follow-up.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Gladys Smok; Cesar Castro; Owen Korn; Ana Henríquez
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

8.  Effect of duodenal diversion on low-grade dysplasia in patients with Barrett's esophagus: analysis of 37 patients.

Authors:  Attila Csendes; Gladys Smok; Patricio Burdiles; Italo Braghetto; Cesar Castro; Owen Korn
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

9.  Overexpression of p53 protein in Barrett's syndrome with malignant transformation.

Authors:  J F Fléjou; F Potet; F Muzeau; F Le Pelletier; F Fékété; D Hénin
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

Review 10.  Preemptive surgery for premalignant foregut lesions.

Authors:  Rohit R Sharma; Mark J London; Laura L Magenta; Mitchell C Posner; Kevin K Roggin
Journal:  J Gastrointest Surg       Date:  2009-06-10       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.